Scott Randal W.
BridgeBio Pharma, Inc. - Common Stock · Director
Scott Randal W. is listed in filings as Director at BridgeBio Pharma, Inc. - Common Stock. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to BridgeBio Pharma, Inc. - Common Stock (BBIO). The current snapshot covers public activity from Jun 24, 2025 to May 19, 2026. Reported amounts are shown as $413.5K to $141.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $362k4.8k shares | SellFeb 17, 2026 | $75.57 | $81.46 | |
| $251k3.3k shares | SellFeb 17, 2026 | $75.93 | $81.46 | |
| $141k1.9k shares | SellFeb 17, 2026 | $74.34 | $81.46 | |
| $415k6.2k shares | SellNov 17, 2025 | $66.89 | $81.46 | |
| $252k3.8k shares | SellNov 17, 2025 | $66.25 | $81.46 |